02.10.2024  12:50:03 Zm. +0,225 Wolumen Bid13:04:01 Ask13:04:01 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
30,375EUR +0,75% 12 096
Obrót: 368 239,065
30,435Wolumen Bid: 1 315 30,435Wolumen Ask: 1 315 29,86 mldEUR 0,36% -

Opis działalności

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen.
 

Zarząd & Rada nadzorcza

CEO
Bill Anderson
Zarząd
Wolfgang Nickl, Heiko Schipper, Rodrigo Santos, Stefan Oelrich, Julio Triana
Rada nadzorcza
Prof. Dr. Norbert Winkeljohann, Heike Hausfeld, Dr. Paul Achleitner, Horst Baier, André van Broich, Ertharin Cousin, Yasmin Fahimi, Dr. Barbara Gansewendt, Colleen A. Goggins, Francesco Grioli, Frank Löllgen, Kimberly Mathisen, Andrea Sacher, Claudia Schade, Lori Schechter, Dr. Nancy Simonian, Jeffrey Ubben, Heinz Georg Webers, Alberto Weisser, Michael Westmeier
 

Dane firmy

Nazwa: Bayer AG
Adres: Kaiser-Wilhelm-Allee 1,D-51368 Leverkusen
Telefon: +49-214-30-1
Fax: +49-214-30-81013
E-mail: info@bayer.com
Internet: www.bayer.de
Przemysł: Surowce naturalne
Sektor: Chemia
Podsektor: -
Koniec roku finansowego: 31.12
Free float: 68,44%
Data IPO: 01.10.1953

Relacje inwestorskie

Nazwa: Oliver Maier
Telefon: +49-214-30-65742
Fax: +49-214-30-9665742
E-mail: oliver.maier@bayer.com